Michael Hecht Olsen

Søgeresultater

• 2012

  NT-proBNP and potential vascular calcification in Black and Caucasian African men: the SAfrEIC study

  Kruger, R., Schutte, R., Huisman, H. W., Olsen, M. H. & Schutte, A. E., 2012, I: Ethnicity & Disease. 22, 4, s. 398-403 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Vascular Calcification 100%
  • Brain Natriuretic Peptide 84%
  • Alkaline Phosphatase 45%
  • Vascular Remodeling 30%
  • Osteoblasts 24%

• NT-proBNP is associated with fibulin-1 in Africans: the SAfrEIC study

  Kruger, R., Schutte, R., Huisman, H. W., Argraves, W. S., Rasmussen, L. M., Olsen, M. H. & Schutte, A. E., 2012, I: Atherosclerosis. 222, 1, s. 216-21 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • fibulin 100%
  • Brain Natriuretic Peptide 69%
  • Elastin 37%
  • Vascular Stiffness 36%
  • Extracellular Matrix Proteins 35%

• Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study

  Larstorp, A. C. K., Okin, P. M., Devereux, R. B., Olsen, M. H., Ibsen, H., Dahlöf, B., Kjeldsen, S. E. & Wachtell, K., 2012, I: American Journal of Hypertension. 25, 10, s. 1101-9 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Left Ventricular Hypertrophy 100%
  • Heart Failure 67%
  • Hypertension 60%
  • Mortality 46%
  • Therapeutics 7%

• The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men

  Haugaard, S. B., Andersen, O., Hansen, T. W., Eugen-Olsen, J., Linneberg, A. R., Madsbad, S., Olsen, M. H., Jørgensen, T., Borch-Johnsen, K. & Jeppesen, J., 2012, I: Diabetic Medicine. 29, 4, s. 479-87 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • International Classification of Diseases 72%
  • Biomarkers 46%
  • Inflammation 42%

• Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts

  Sehestedt, T. B., Jeppesen, J., Hansen, T. W., Rasmussen, S. L., Wachtell, K., Ibsen, H., Torp-Pedersen, C. T. & Olsen, M. H., 2012, I: Journal of Hypertension. 30, 10, s. 1928-36 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Pulse Wave Analysis 100%
  • Albumins 71%
  • Creatinine 66%
  • Urine 59%
• 2011

  Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

  Larstorp, A. C. K., Okin, P. M., Devereux, R. B., Olsen, M. H., Ibsen, H., Dahlöf, B., Kjeldsen, E. & Wachtell, K., 2011, I: Journal of Human Hypertension. 25, 3, s. 178-85 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Left Ventricular Hypertrophy 100%
  • Hypertension 60%
  • Blood Pressure 59%
  • Losartan 27%
  • Antihypertensive Agents 21%

• Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

  Olsen, M. H., Wachtell, K., Ibsen, H., Lindholm, L., Kjeldsen, S. E., Omvik, P., Nieminen, M. S., Dahlöf, B., Okin, P. M. & Devereux, R. B., 2011, I: International Journal of Hypertension. 29, 5, s. 997-1004 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Left Ventricular Hypertrophy 100%
  • Risk Reduction Behavior 94%
  • Antihypertensive Agents 85%
  • Albumins 79%
  • Creatinine 73%

• Impaired left ventricular systolic function in patients with left ventricular hypertrophy

  Wachtell, K. & Olsen, M. H., 2011, I: Journal of Hypertension. 29, 11, s. 2068-2069

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• N-terminal Prohormone B-type Natriuretic Peptide and Cardiovascular Function in Africans and Caucasians: The SAfrEIC Study

  Kruger, R., Schutte, R., Huisman, H. W., Hindersson, P., Olsen, M. H. & Schutte, A. E., 2011, I: Heart, Lung and Circulation. 21, 2, s. 88-95

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • pro-brain natriuretic peptide (1-76) 100%
  • Brain Natriuretic Peptide 83%
  • Namibia 38%
  • Pulse Wave Analysis 30%
  • South Africa 26%

• Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Metabolic Changes in HIV-1-Infected Africans: A Prospective Study

  Fourie, C. M. T., Van Rooyen, J. M., Kruger, A., Olsen, M. H., Eugen-Olsen, J., Schutte, R. & Schutte, A. E., 2011, I: Inflammation. 35, 1, s. 221-9 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • HIV-1 62%
  • Prospective Studies 45%
  • Lipodystrophy 24%
  • HIV 12%

• Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

  Sehestedt, T., Lyngbæk, S., Eugen-Olsen, J., Jeppesen, J., Andersen, O., Hansen, T. W., Linneberg, A. R., Jørgensen, T., Pape-Haugaard, L. B. & Olsen, M. H., 2011, I: Atherosclerosis. 216, 1, s. 237-243

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Urokinase Plasminogen Activator Receptors 100%
  • Inflammation 21%

• Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure

  Redon, J., Olsen, M. H., Cooper, R. S., Zurriaga, O., Martinez-Beneito, M. A., Laurent, S., Cifkova, R., Coca, A. & Mancia, G., 2011, I: European Heart Journal (English Edition). 32, 11, s. 1424-31 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Central Asia 100%
  • Stroke 44%
  • Hypertension 42%
  • Blood Pressure 41%
  • Mortality 32%